Rg1 specifically upregulates activating transcription factor (ATF) 3/acyl-coenzyme A oxidase (ACOX) 2 to alleviate NAFLD, and how Rg1 regulates NAFLD through these two genes is unknown (Gu et al., 2021). Here, PPP1R3A is linked to metabolic dysfunction-associated steatotic liver disease.